CAPR Capricor Therapeutics Inc Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
03:22
Oct 04
u/TreeofLibertyFood
r/biotech_stocks
Holds CAPR for PDUFA and HOPE-3 data
Author holds Capricor shares bought at low prices and argues it is more likely than not to receive narrow-label approval, with a PDUFA date of 11/22 and expected HOPE-3 24-month data release soon. The approval decision and the data readout are the stated catalysts that could make it the first of the three to moon. Main risk implied is the binary regulatory/data outcome, though the author does not spell out a downside scenario.
CAPR Capricor Therapeutics Inc Long 1ST Position: Holding —
13:44
Jul 27
seedy19tron
Sell/short CAPR — author argues FDA approval is unlikely because the trial changed its.
Sell/short CAPR — author argues FDA approval is unlikely because the trial changed its pre-specified endpoint and the LVEF result remains barely statistically significant even after that change, suggesting the underlying data is too weak to pass regulatory scrutiny.
CAPR Capricor Therapeutics Inc Short 2ND — —
12:07
Jul 27
Martin Shkreli
Short CAPR as Shkreli alleges imminent criminal charges against the CEO and a statistics.
Short CAPR as Shkreli alleges imminent criminal charges against the CEO and a statistics consultant for patient data manipulation — a fraud allegation of this nature risks trial invalidation, FDA scrutiny, and leadership collapse in a small-cap biotech.
CAPR Capricor Therapeutics Inc Short — —
Log in to see ideas

About CAPR Investor Commentary

Across the available history and selected sources, Buzzberg tracks CAPR (Capricor Therapeutics Inc) across 14 sources: 3 bullish vs 3 bearish calls from 15 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 53 total trade ideas tracked. Latest voices: u/TreeofLibertyFood, seedy19tron, Martin Shkreli.